Patents by Inventor Nigel William Fraser

Nigel William Fraser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of Melanoma Using HSV Mutant
    Publication number: 20120141418
    Abstract: Use as an anti-cancer agent of a mutant herpes simplex virus wherein the mutant virus comprises a modification in the ?34.5 gene in the long repeat region (RL) such that the ?34.5 gene is a non-functional, manufacture of medicaments and methods of testing cancer in mammals employing HSV mutant.
    Type: Application
    Filed: November 28, 2011
    Publication date: June 7, 2012
    Applicants: THE WISTAR INSTITUTE, Virttu Biologics Limited
    Inventors: Alasdair Roderick MacLean, Susanne Moira Brown, Nigel William Fraser, Bruce Paul Randazzo
  • Treatment of melanoma using HSV mutant
    Patent number: 8067012
    Abstract: Use as an anti-cancer agent of a mutant herpes simplex virus wherein the mutant virus comprises a modification in the ?34.5 gene in the long repeat region (RL) such that the ?34.5 gene is a non-functional, manufacture of medicaments and methods of testing cancer in mammals employing HSV mutant.
    Type: Grant
    Filed: January 22, 2010
    Date of Patent: November 29, 2011
    Assignees: Crusade Laboratories Limited, The Wistar Institute
    Inventors: Alasdair Roderick MacLean, Susanne Moira Brown, Nigel William Fraser, Bruce Paul Randazzo
  • Treatment of Cancer Using HSV Mutant
    Publication number: 20100172872
    Abstract: Use as an anti-cancer agent of a mutant herpes simplex virus wherein the mutant virus comprises a modification in the ?34.5 gene in the long repeat region (RL) such that the ?34.5 gene is a non-functional, manufacture of medicaments and methods of testing cancer in mammals employing HSV mutant.
    Type: Application
    Filed: January 22, 2010
    Publication date: July 8, 2010
    Applicants: CRUSADE LABORATORIES LIMITED, THE WISTAR INSTITUTE
    Inventors: Alasdair Roderick MacLean, Susanne Moira Brown, Nigel William Fraser, Bruce Paul Randazzo
  • Treatment of cancer using HSV mutant
    Patent number: 7674468
    Abstract: Use as an anti-cancer agent of a mutant herpes simplex virus wherein the mutant virus comprises a modification in the ?34.5 gene in the long repeat region (RL) such that the ?34.5 gene is a non-functional, manufacture of medicaments and methods of testing cancer in mammals employing HSV mutant.
    Type: Grant
    Filed: June 13, 2005
    Date of Patent: March 9, 2010
    Assignees: Crusade Laboratories Limited, The Wistar Institute
    Inventors: Alasdair Roderick MacLean, Susanne Moira Brown, Nigel William Fraser, Bruce Paul Randazzo